Corcept Therapeutics (CORT)
NASDAQ: CORT
· Real-Time Price · USD
71.50
-0.38 (-0.53%)
At close: May 01, 2025, 2:49 PM
Corcept Therapeutics Revenue
Corcept Therapeutics reported an annual revenue of $675.04M, reflecting a 39.94% growth. For the quarter ending December 31, 2024, Corcept Therapeutics generated $181.89M in revenue.
Revenue (ttm)
$675.04M
Revenue Growth
39.94%
Price / Sales Ratio
7.71
Revenue / Employee
$1.35M
Employees
500
Market Cap
7.54B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 675.04M | +39.94% |
| Dec 31, 2023 | 482.38M | +20.04% |
| Dec 31, 2022 | 401.86M | +9.80% |
| Dec 31, 2021 | 365.98M | +3.42% |
| Dec 31, 2020 | 353.87M | n/a |